U.S. federal trademark · Serial No. 99104160 · Reg. No. 019090431
Conducting of medical, scientific and clinical research in the field of engineered T-cell receptor-based immunotherapy against solid cancer; medical and scientific research in the nature of conducting clinical trials for others in the field of engineered T-cell receptor-based immunotherapy against solid cancer, and providing corresponding medical and scientific research information
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.